Sirolimus in COVID-19 Phase 1

NCT04371640 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study population not regularly admitted to hospital and approaches have shifted away from repurposing old drugs.

Conditions

SARS-CoV-2
Covid-19

Interventions

DRUG: Sirolimus 1 MG/ML
DRUG: Placebo

Sponsor

Walter K. Kraft